LifeTech Scientific Corporation
LFTSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7,464 | $6,745 | $9,927 | $18,840 |
| - Cash | $666 | $979 | $834 | $1,119 |
| + Debt | $5 | $9 | $10 | $16 |
| Enterprise Value | $6,803 | $5,775 | $9,103 | $17,736 |
| Revenue | $1,304 | $1,267 | $1,097 | $925 |
| % Growth | 2.9% | 15.5% | 18.6% | – |
| Gross Profit | $981 | $996 | $874 | $748 |
| % Margin | 75.3% | 78.6% | 79.6% | 80.8% |
| EBITDA | $289 | $253 | $446 | $398 |
| % Margin | 22.2% | 20% | 40.6% | 43% |
| Net Income | $222 | $263 | $325 | $292 |
| % Margin | 17.1% | 20.8% | 29.6% | 31.6% |
| EPS Diluted | 0.051 | 0.059 | 0.074 | 0.064 |
| % Growth | -13.9% | -20% | 15.6% | – |
| Operating Cash Flow | $321 | $418 | $388 | $489 |
| Capital Expenditures | -$283 | -$293 | -$335 | -$343 |
| Free Cash Flow | $38 | $125 | $53 | $146 |